|
|
||||||||
Department of Medicine, Harvard Medical School and the Robert B. Brigham Hospital, Boston, Massachusetts 02120
Abstract
Phosphatidylserine (PTS) enhances the antigen-induced release of preformed vasoactive amines from rat mast cells both in vivo and in vitro without enhancing the release in vivo of slow reacting substance of anaphylaxis (SRS-A). The duration of mediator release from mast cells is not prolonged by PTS but enhancement is observed when PTS is added before and for as long as 3 min after antigen challenge. PTS enhancement requires intact glycolysis and the presence of calcium ions; it is inhibited by magnesium ions and oligomycin. Antigen-induced release and PTS enhancement are suppressed by agents which increase intracellular levels of cyclic adenosine 3'5'-monophosphate and by the addition of exogenous cyclic AMP in the dibutyryl form.
Footnotes
1 This work was supported by Grant AI-07722 from the National Institutes of Health.
2 Former Recipient of Research Career Development Award 5K04 AI 28,405-02. Present address: Department of Medicine, The University of Kansas Medical Center, Kansas City, Kansas 66103.
This article has been cited by other articles:
![]() |
T. Martin and D Lagunoff Inhibition of mast cell histamine secretion by N-substituteed derivatives of phosphatidylserine Science, May 11, 1979; 204(4393): 631 - 633. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |